THE distributor of the Spikevax vaccine from Moderna said it will apply for a certificate of product registration to enable the commercial availability of the vaccine in the Philippines.
In an email interview with The Manila Times, Dr. Philip Nakpil, medical director of ZP Therapeutics Philippines, said it will apply for a CPR once it receives the relevant data regarding the safety profile of its vaccine and with the guidance of the Philippine Food and Drug Administration (FDA) and the Department of Health (DoH).
Already have an active account? Log in here to continue
reading.
Or Subscribe
to the Premium
Subscription plan to access this subscriber-exclusive article.